AOU L. Vanvitelli Universita degli Studi della Campania Luigi Vanvitelli
Naples 80138
1 studies enrolling now · 3 studies all time
What they study most
End Stage Kidney Disease, Non-Transfusion-dependent Alpha-Thalassemia, Non-Transfusion-dependent Beta-Thalassemia, Transfusion-dependent Alpha-Thalassemia, Transfusion-dependent Beta-Thalassemia
Studies at this site
- Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
- A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-NTDT) — Running, not enrolling
- A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT) — Running, not enrolling